Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Daliani

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Leukemia & Lymphoma|July 31, 1998
Tumor necrosis factor-alpha and interferon-gamma, but not HTLV-I tax, are likely factors in the epidermotropism of cutaneous T-cell lymphoma via induction of interferon-inducible protein-10D Daliani, R A Ulmer, C Jackow, et al.
Cancer|September 5, 2002
A pilot study of thalidomide in patients with progressive metastatic renal cell carcinomaDanai D Daliani, Christos N Papandreou, Peter F Thall, et al.
Journal of Negative Results in Biomedicine|January 7, 2012
Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancerPanagiotis J Vlachostergios, Foteini Karasavvidou, Grigorios Kakkas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2002
Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostateChristos N Papandreou, Danai D Daliani, Peter F Thall, et al.
Clinical Genitourinary Cancer|October 10, 2006
Thalidomide/estramustine/paclitaxel in metastatic androgen-independent prostate cancerPaul Mathew, Christopher J Logothetis, Pauline Y Dieringer, et al.
Urologia Internationalis|January 31, 2012
CD10 is inversely associated with nuclear factor-kappa B and predicts biochemical recurrence after radical prostatectomyIoannis A Voutsadakis, Panagiotis J Vlachostergios, Danai D Daliani, et al.
The Journal of Urology|February 11, 2003
Suppression of prostate cancer induced bone remodeling by the endothelin receptor A antagonist atrasentanJoel B Nelson, Azmi A Nabulsi, Nicholas J Vogelzang, et al.
Leukemia & Lymphoma|December 1, 1996
Interferon-inducible protein-10 and the pathogenesis of cutaneous T-cell lymphomasA H Sarris, D Daliani, R Ulmer, et al.
Cancer|January 28, 2003
Phase II trial of cyclophosphamide, vincristine, and dexamethasone in the treatment of androgen-independent prostate carcinomaDanai D Daliani, Vasily Assikis, Shi-Ming Tu, et al.
BJU International|April 3, 2009
Prospective assessment of systemic therapy followed by surgical removal of metastases in selected patients with renal cell carcinomaDanai D Daliani, Nizar M Tannir, Christos N Papandreou, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Leukemia & Lymphoma|July 31, 1998
Tumor necrosis factor-alpha and interferon-gamma, but not HTLV-I tax, are likely factors in the epidermotropism of cutaneous T-cell lymphoma via induction of interferon-inducible protein-10D Daliani, R A Ulmer, C Jackow, et al.
Cancer|September 5, 2002
A pilot study of thalidomide in patients with progressive metastatic renal cell carcinomaDanai D Daliani, Christos N Papandreou, Peter F Thall, et al.
Journal of Negative Results in Biomedicine|January 7, 2012
Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancerPanagiotis J Vlachostergios, Foteini Karasavvidou, Grigorios Kakkas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2002
Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostateChristos N Papandreou, Danai D Daliani, Peter F Thall, et al.
Clinical Genitourinary Cancer|October 10, 2006
Thalidomide/estramustine/paclitaxel in metastatic androgen-independent prostate cancerPaul Mathew, Christopher J Logothetis, Pauline Y Dieringer, et al.
Urologia Internationalis|January 31, 2012
CD10 is inversely associated with nuclear factor-kappa B and predicts biochemical recurrence after radical prostatectomyIoannis A Voutsadakis, Panagiotis J Vlachostergios, Danai D Daliani, et al.
The Journal of Urology|February 11, 2003
Suppression of prostate cancer induced bone remodeling by the endothelin receptor A antagonist atrasentanJoel B Nelson, Azmi A Nabulsi, Nicholas J Vogelzang, et al.
Leukemia & Lymphoma|December 1, 1996
Interferon-inducible protein-10 and the pathogenesis of cutaneous T-cell lymphomasA H Sarris, D Daliani, R Ulmer, et al.
Cancer|January 28, 2003
Phase II trial of cyclophosphamide, vincristine, and dexamethasone in the treatment of androgen-independent prostate carcinomaDanai D Daliani, Vasily Assikis, Shi-Ming Tu, et al.
BJU International|April 3, 2009
Prospective assessment of systemic therapy followed by surgical removal of metastases in selected patients with renal cell carcinomaDanai D Daliani, Nizar M Tannir, Christos N Papandreou, et al.
Pageof 4